This is the main conclusion of the study Spanish Predimed (Prevention with Mediterranean diet), which has been published in the medical journal of greater international impact.

The Mediterranean Diet supplemented with extra-virgin olive oil or dried fruits (nuts, hazelnuts and almonds) reduces as much as 30 percent the risk of major cardiovascular complications (Myocardial Infarction, stroke or cardiovascular death) in patients at high cardiovascular risk.

This is the main conclusion of the study Spanish Predimed (Prevention with Mediterranean Diet) which has been published in the medical journal the greatest international impact 'The New England Journal of Medicine' as has been highlighted on Monday from the Andalusian Ministry Health and Welfare.

Predimed study, in which they have participated voluntarily in Spain 7,447 patients without known cardiovascular disease and has included more than 1,000 Andalusian, is the largest randomized clinical trial ever undertaken in the state and one of the most nutritional studies important conducted worldwide. It has meant ten years of work of 19 research groups in Andalusia, the Balearic Islands, Catalonia, Navarra, Basque Country and Valencia, coordinated by Ramon Estruch Clinical Hospital of Barcelona.

Andalusia has contributed significantly to the study because 1400 patients have participated Andalusians and three research groups of the autonomous community belonging to Sevilla Primary Health District, the Department of Preventive Medicine, Faculty of Medicine, University of Malaga and the Institute for Fat Research Council scientific Sevilla.

The research group of Sevilla Primary Health District has been coordinated by José Lapetra, specialist in Family Medicine and Community Health Centre St. Paul. He was the only participant research group from the baseline in 2003, comprised entirely of primary care health professionals.

Moreover, since 2006, the group is part of the Center for Biomedical Network Research (CIBER) Pathophysiology of Obesity and Nutrition (CIBERobn) of the Carlos III Health Institute.

Published in the New England Journal of Medicine

to continue...